TGA announces major internal structural change in order to enhance regulatory efficiency

September 22, 2011 | BY Paul Cohen

TGA (Therapeutic Goods Administration) restructures its internal organization combined with an increased use of information technology to ensure a more efficient regulatory review and continuous post market supervision process. Two separate regulatory groups have been created, one that will focus on authorizations for product market access and another group monitoring products already on the market.


During a period of transition, TGA assures business as usual and encourages industry to continue to liaise with current TGA contacts.